NLS-Cas9-EGFP
search
  • NLS-Cas9-EGFP

NLS-Cas9-EGFP

Catalog # PR-137211-E

Print

$252.00

NLS‐Cas9‐EGFP-NLS is a fusion protein containing a nuclear localization sequence (NLS) on its N terminal and EGFP-NLS on the C terminal. 

Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

For molar concentration and other related product information, please refer to:    CRISPR/Cas9 related enzyme proteins, antibodies, and other reagents


In vitro Cas9 mediated digestion of DNA

 

1. Add the following components to a sterile, nuclease-free tube on ice:

 

Components

Volume

Final Concentration

 

sgRNA (300 nM)

2 µl

~30 nM

 

Cas9-EGFP Nuclease Protein

(1000 nM)

0.60 µl

~30 nM

 

10X Cas9 Nuclease Reaction

Buffer

2 μl

1X

 

Nuclease-free H2O

12.4 μl

-

 

Pre-Incubate for 15 minutes at room temperature

 

Substrate DNA (30 nM)

3 μl

3 nM

 

Total Volume

20 μl

-

 

 

2. Collect all components by a brief centrifugation. Incubate the reaction at 37 °C for 1 hour.

3. Analyze fragments by running an agarose gel electrophoresis, or do transfection for target gene tracking.

 

 References:

1.  Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA    Amin Aalipour et al. Clinical Chemistry 2018 Vol. 64, Issue 2 p307-p916
2. Purified Cas9 Fusion Proteins for Advanced Genome Manipulation Jovan Mircetic et al. Small Methods 2017 1, 1600052
3. Disruptive non-disruptive applications of CRISPR/Cas9  Jonathan LSchmid-Burgk  Current Opinion in Biotechnology December 2017, Volume 48 Pages 203-209
4. Efficient sequence-specific isolation of DNA fragments and chromatin by in vitro enChIP  technology using recombinant CRISPR ribonucleoproteins Toshitsugu Fujita et al. Genes to Cells  Volume 21, Issue 4 April 2016  Pages 370–377
5. High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding Evan A Boyle  et al. PNAS 2017 May, 114 (21) 5461-5466
6.CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells  Wulan Deng et al. PNAS2015 vol. 112 | no. 38 p11870-11875

Related Products

NLS-Cas9-NLS     NLS-Cas9-EGFP               NLS-Cas9(D10A)-2NLS nickase 

dCas9 (D10A & H840A)       NLS-dCas9-NLS        Biotinylated NLS-dCas9-NLS

dCas9-SBP       NLS-dCas9 -EGFP-NLS               LbCas12a (Cpf1) Nuclease

eSpCas9(1.1)-3NLS              SpCas9-HF1-3NLS             Cas9 ELISA kit

Cas9 Monoclonal Antibody    Cas9 monoclonal antibody, biotinylated



Data sheet

Storage
-70°C. Avoid freeze thaw cycles.
Background
NLS‐Cas9‐EGFP-NLS is a fusion protein containing a nuclear localization sequence (NLS) on its N terminal and EGFP-NLS on the C terminal. The Cas9 RNP complex can localize to the nucleus immediately upon entering the cell. The EGFP can be taken as a report
Formulation
Recombinant NLS-Cas9-EGFP-NLS protein expressed in E. coli supplied in a buffer of
10 mM Tris‐HCl (pH 7.4), 0.1 mM EDTA, 1 mM DTT, 300 mM NaCl, and 50% (v/v) Glycerol.
Concentration
50 μg/ 50 μl or 1 μg/μl or molar concentration 5.31 µM.
New